Skip to main content
Paul S. Bernstein
( out of 641 reviews )

Paul S. Bernstein, MD, PhD

Languages spoken: English

Clinical Locations

Primary Location

Midvalley Health Center

Moran Eye Center
243 East 6100 South
Murray , UT 84107

John A. Moran Eye Center

65 N Mario Capecchi
Salt Lake City , UT 84132

Paul S. Bernstein, MD, PhD, divides his time between basic science retina research and a clinical practice devoted to medical and surgical treatment of diseases of the retina at the John A. Moran Eye Center at the University of Utah, where he has been a faculty member since 1995. He holds the Val A. and Edith D. Green Presidential Endowed Chair in Ophthalmology and Visual Sciences and is Moran’s Vice-Chair for Clinical and Basic Science Research. He has adjunct appointments in the University of Utah Department of Pharmacology and Toxicology, Department of Neurobiology and Anatomy, and Division of Neurosciences.

His clinical expertise includes age-related macular degeneration with special emphasis on the role of nutrition and environment in its treatment and prevention, inherited retinal and macular dystrophies, and surgical treatment of vitreoretinal disorders such as diabetic retinopathy and retinal detachments.

Dr. Bernstein did his undergraduate, MD, and PhD training at Harvard University. Highlights of his training at Harvard included a summa cum laude undergraduate degree in chemistry and a PhD thesis entitled “Biochemistry and Pharmacology of Rhodopsin Regeneration in the Vertebrate Eye” with Dr. Robert Rando of the Department of Pharmacology. His medical degree was from the Division of Health Sciences and Technology, a special joint program between Harvard Medical School and the Massachusetts Institute of Technology. After completing 12 years at Harvard, he moved to UCLA where he did a post-doctoral fellowship with Dr. Dean Bok in retinal cell biology and a residency in Ophthalmology at the Jules Stein Eye Institute. He then returned to Harvard for two more years for a fellowship in vitreoretinal research and surgery at the Massachusetts Eye and Ear Infirmary.

Dr. Bernstein has authored over 200 peer-reviewed research articles and reviews as well as over a dozen book chapters and has served as a reviewer for numerous journals, foundations, and institutes. His lab research interests include biochemistry and biophysics of nutritional interventions against inherited and acquired ocular disorders and the genetics and imaging of macular telangiectasia type 2 (MacTel)—a notoriously difficult-to-diagnose hereditary disease that causes central vision loss. He is among the first researchers worldwide to test the early diagnostic capabilities of fluorescence lifetime imaging ophthalmoscopy, a new non-invasive retinal imaging technique known as FLIO.

He has received numerous awards, including the 2020 Mildred Weisenfeld Award from the Association for Research in Vision and Ophthalmology; the Macula Society’s 2019 W. Richard Green Lecture in honor of work that has helped explain the pathogenesis of retinal diseases; and the American Academy of Ophthalmology’s 2016 Outstanding Humanitarian Service Award.

Dr. Bernstein is also dedicated to bringing modern vitreoretinal services to the developing world in a sustainable manner. Currently, access to retinal care is extremely limited in many parts of the world, and Dr. Bernstein provides hands-on specialty training to help expand the availability and quality of care. Dr. Bernstein has worked with Moran’s Global Outreach Division and the Himalayan Cataract Project to train aspiring retina specialists from Nepal, Ghana, Ethiopia, and Bhutan.

Get to know Dr. Bernstein by watching his profile video.

Board Certification

National Board of Medical Examiners

Patient Rating

4.8 /5
( out of 641 reviews )

The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

The scale on which responses are measured is 1 to 5 with 5 being the best score.

Patient Comments

Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

MORAN EYE CENTER

He was very kind, explained my diagnosis and the path moving forward ! I was very impressed with his manner and knowledge! It was a very positive appointment!

MORAN EYE CENTER

Would never recommend him.

MORAN EYE CENTER

Excellent provider, I trust him

MORAN EYE CENTER

Top rated retina specialist who is doing research.

MORAN EYE CENTER

Very professional

MORAN EYE CENTER

Very good care

MORAN EYE CENTER

Dr Bernstein is excellent.

MORAN EYE CENTER

Very professional and yet extremely kind and friendly.

MORAN EYE CENTER

He is best and we feel blessed he was able do my surgery

Paul S. Bernstein, MD, PhD, divides his time between basic science retina research and a clinical practice devoted to medical and surgical treatment of diseases of the retina at the John A. Moran Eye Center at the University of Utah, where he has been a faculty member since 1995. He holds the Val A. and Edith D. Green Presidential Endowed Chair in Ophthalmology and Visual Sciences and is Moran’s Vice-Chair for Clinical and Basic Science Research. He has adjunct appointments in the University of Utah Department of Pharmacology and Toxicology, Department of Neurobiology and Anatomy, and Division of Neurosciences.

His clinical expertise includes age-related macular degeneration with special emphasis on the role of nutrition and environment in its treatment and prevention, inherited retinal and macular dystrophies, and surgical treatment of vitreoretinal disorders such as diabetic retinopathy and retinal detachments.

Dr. Bernstein did his undergraduate, MD, and PhD training at Harvard University. Highlights of his training at Harvard included a summa cum laude undergraduate degree in chemistry and a PhD thesis entitled “Biochemistry and Pharmacology of Rhodopsin Regeneration in the Vertebrate Eye” with Dr. Robert Rando of the Department of Pharmacology. His medical degree was from the Division of Health Sciences and Technology, a special joint program between Harvard Medical School and the Massachusetts Institute of Technology. After completing 12 years at Harvard, he moved to UCLA where he did a post-doctoral fellowship with Dr. Dean Bok in retinal cell biology and a residency in Ophthalmology at the Jules Stein Eye Institute. He then returned to Harvard for two more years for a fellowship in vitreoretinal research and surgery at the Massachusetts Eye and Ear Infirmary.

Dr. Bernstein has authored over 200 peer-reviewed research articles and reviews as well as over a dozen book chapters and has served as a reviewer for numerous journals, foundations, and institutes. His lab research interests include biochemistry and biophysics of nutritional interventions against inherited and acquired ocular disorders and the genetics and imaging of macular telangiectasia type 2 (MacTel)—a notoriously difficult-to-diagnose hereditary disease that causes central vision loss. He is among the first researchers worldwide to test the early diagnostic capabilities of fluorescence lifetime imaging ophthalmoscopy, a new non-invasive retinal imaging technique known as FLIO.

He has received numerous awards, including the 2020 Mildred Weisenfeld Award from the Association for Research in Vision and Ophthalmology; the Macula Society’s 2019 W. Richard Green Lecture in honor of work that has helped explain the pathogenesis of retinal diseases; and the American Academy of Ophthalmology’s 2016 Outstanding Humanitarian Service Award.

Dr. Bernstein is also dedicated to bringing modern vitreoretinal services to the developing world in a sustainable manner. Currently, access to retinal care is extremely limited in many parts of the world, and Dr. Bernstein provides hands-on specialty training to help expand the availability and quality of care. Dr. Bernstein has worked with Moran’s Global Outreach Division and the Himalayan Cataract Project to train aspiring retina specialists from Nepal, Ghana, Ethiopia, and Bhutan.

Get to know Dr. Bernstein by watching his profile video.

Board Certification and Academic Information

Academic Departments Neurobiology -Adjunct Professor
Ophthalmology & Visual Sciences -Professor
Board Certification
National Board of Medical Examiners

Education history

Undergraduate Chemistry, summa cum laude - Harvard University A.B.
Professional Medical Medicine - Harvard Medical School/MIT - Division of Health Sciences & Technology M.D.
Doctoral Training Pharmacology - Harvard University Ph.D.
Internship Internal Medicine - New England Deaconess Hospital Intern
Postdoctoral Fellowship Cell Biology - UCLA Medical Center, Jules Stein Eye Institute Postdoctoral Fellow
Residency Ophthalmology - UCLA Medical Center, Jules Stein Eye Institute Resident
Fellowship Vitreoretinal Surgery - Massachusetts Eye and Ear Infirmary Fellow

Selected Publications

Journal Article

  1. Li B, Rognon GT, Mattinson T, Vachali PP, Gorusupudi A, Chang FY, Ranganathan A, Nelson K, George EW, Frederick JM, Bernstein P (2018). Supplementation with macular carotenoids improves visual performance of transgenic mice. Archives of biochemistry and biophysics, 649, 22-28.
  2. Bhosale P, Bernstein P (2005). Microbial xanthophylls. Applied microbiology and biotechnology, 68(4), 445-55.
  3. Sauer L, Li B, Bernstein P (2019). Ocular Carotenoid Status in Health and Disease. Annual review of nutrition, 39, 95-120.
  4. Fujinami K, Strauss RW, Chiang JP, Audo IS, Bernstein PS, Birch DG, Bomotti SM, Cideciyan AV, Ervin AM, Marino MJ, Sahel JA, Mohand-Said S, Sunness JS, Traboulsi EI, West S, Wojciechowski R, Zrenner E, Michaelides M, Scholl HPN, ProgStar Study Group., ProgStar Study Group (2019). Detailed genetic characteristics of an international large cohort of patients with Stargardt disease: ProgStar study report 8. The British journal of ophthalmology, 103(3), 390-397.
  5. Bernstein PS, Gellermann (2002). Measurement of carotenoids in the living primate eye using resonance Raman spectroscopy. Methods in molecular biology (Clifton, N.J.), 196, 321-9.
  6. Arunkumar R, Gorusupudi A, Li B, Blount JD, Nwagbo U, Kim HJ, Sparrow JR, Bernstein P (2021). Lutein and zeaxanthin reduce A2E and iso-A2E levels and improve visual performance in Abca4-/-/Bco2-/- double knockout mice. Experimental eye research, 209, 108680.
  7. Arunkumar R, Calvo CM, Conrady CD, Bernstein P (2018). What do we know about the macular pigment in AMD: the past, the present, and the future. Eye (London, England), 32(5), 992-1004.
  8. Sauer L, Vitale AS, Modersitzki NK, Bernstein P (2021). Fluorescence lifetime imaging ophthalmoscopy: autofluorescence imaging and beyond. Eye (London, England), 35(1), 93-109.
  9. Obana A, Gohto Y, Sasano H, Gellermann W, Sharifzadeh M, Seto T, Bernstein P (2018). Grade of Cataract and Its Influence on Measurement of Macular Pigment Optical Density Using Autofluorescence Imaging. Investigative ophthalmology & visual science, 59(7), 3011-3019.
  10. Sauer L, Andersen KM, Li B, Gensure RH, Hammer M, Bernstein P (2018). Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO) of Macular Pigment. Investigative ophthalmology & visual science, 59(7), 3094-3103.
  11. Sauer L, Komanski CB, Vitale AS, Hansen ED, Bernstein P (2019). Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO) in Eyes With Pigment Epithelial Detachments Due to Age-Related Macular Degeneration. Investigative ophthalmology & visual science, 60(8), 3054-3063.
  12. Bhosale P, Zhao DY, Bernstein P (2007). HPLC measurement of ocular carotenoid levels in human donor eyes in the lutein supplementation era. Investigative ophthalmology & visual science, 48(2), 543-9.
  13. da Palma MM, Igelman AD, Ku C, Burr A, You JY, Place EM, Wang NK, Oh JK, Branham KE, Zhang X, Ahn J, Gorin MB, Lam BL, Ronquillo CC, Bernstein PS, Nagiel A, Huckfeldt R, Cabrera MT, Kelly JP, Bakall B, Iannaccone A, Hufnagel RB, Zein WM, Koenekoop RK, Birch DG, Yang P, Fahim AT, Pennesi M (2021). Characterization of the Spectrum of Ophthalmic Changes in Patients With Alagille Syndrome. Investigative ophthalmology & visual science, 62(7), 27.
  14. Bernstein PS, Arunkumar (2021). The emerging roles of the macular pigment carotenoids throughout the lifespan and in prenatal supplementation. Journal of lipid research, 62, 100038.
  15. Bernstein PS, Ranganathan (2021). The emerging roles of the macular pigment carotenoids throughout the lifespan and in prenatal supplementation. Journal of lipid research, 100038.
  16. Obana A, Gohto Y, Sasano H, Gellermann W, Sharifzadeh M, Seto T, Bernstein P (2020). Spatial distribution of macular pigment estimated by autofluorescence imaging in elderly Japanese individuals. Japanese journal of ophthalmology, 64(2), 160-170.
  17. Gantner ML, Eade K, Wallace M, Handzlik MK, Fallon R, Trombley J, Bonelli R, Giles S, Harkins-Perry S, Heeren TFC, Sauer L, Ideguchi Y, Baldini M, Scheppke L, Dorrell MI, Kitano M, Hart BJ, Cai C, Nagasaki T, Badur MG, Okada M, Woods SM, Egan C, Gillies M, Guymer R, Eichler F, Bahlo M, Fruttiger M, Allikmets R, Bernstein PS, Metallo CM, Friedlander (2019). Serine and Lipid Metabolism in Macular Disease and Peripheral Neuropathy. The New England journal of medicine, 381(15), 1422-1433.
  18. Li B, George EW, Rognon GT, Gorusupudi A, Ranganathan A, Chang FY, Shi L, Frederick JM, Bernstein P (2020). Imaging lutein and zeaxanthin in the human retina with confocal resonance Raman microscopy. Proceedings of the National Academy of Sciences of the United States of America, 117(22), 12352-12358.
  19. Zucker CL, Bernstein PS, Schalek RL, Lichtman JW, Dowling J (2020). A connectomics approach to understanding a retinal disease. Proceedings of the National Academy of Sciences of the United States of America, 117(31), 18780-18787.
  20. Gorusupudi A, Rallabandi R, Li B, Arunkumar R, Blount JD, Rognon GT, Chang FY, Wade A, Lucas S, Conboy JC, Rainier JD, Bernstein P (2021). Retinal bioavailability and functional effects of a synthetic very-long-chain polyunsaturated fatty acid in mice. Proceedings of the National Academy of Sciences of the United States of America, 118(6),
  21. Ronquillo CC, Sauer L, Morgan D, Heckzo JB, Creel DJ, Mamalis N, DeAngelis MM, Hagemann GS, Bernstein P (2019). ABSENCE OF MACULAR DEGENERATION IN A PATIENT WITH ACERULOPLASMINEMIA. Retina (Philadelphia, Pa.), 39(9), 1824-1828.
  22. Sauer L, Vitale AS, Andersen KM, Hart B, Bernstein P (2020). FLUORESCENCE LIFETIME IMAGING OPHTHALMOSCOPY (FLIO) PATTERNS IN CLINICALLY UNAFFECTED CHILDREN OF MACULAR TELANGIECTASIA TYPE 2 (MACTEL) PATIENTS. Retina (Philadelphia, Pa.), 40(4), 695-704.
  23. Sauer L, Vitale AS, Modersitzki NK, Bernstein P (2021). LONGITUDINAL FLUORESCENCE LIFETIME IMAGING OPHTHALMOSCOPY ANALYSIS IN PATIENTS WITH MACULAR TELANGIECTASIA TYPE 2 (MacTel). Retina (Philadelphia, Pa.), 41(7), 1416-1427.
  24. Sauer L, Andersen KM, Dysli C, Zinkernagel MS, Bernstein PS, Hammer (2018). Review of clinical approaches in fluorescence lifetime imaging ophthalmoscopy. Journal of biomedical optics, 23(9), 1-20.
  25. Rai BB, Morley MG, Bernstein PS, Maddess (2020). Pattern of vitreo-retinal diseases at the national referral hospital in Bhutan: a retrospective, hospital-based study. BMC ophthalmology, 20(1), 51.
  26. Rai BB, Morley MG, Zangmo P, Tshering T, Khatiwara AN, Bernstein PS, Maddess (2020). Retinal laser services in Bhutan: a 3-year national survey. BMC ophthalmology, 20(1), 404.
  27. Wade A, Rallabandi R, Lucas S, Oberg C, Gorusupudi A, Bernstein PS, Rainier J (2021). The synthesis of the very long chain polyunsaturated fatty acid (VLC-PUFA) 32:6 n-3. Organic & biomolecular chemistry, 19(25), 5563-5566.
  28. Gorusupudi A, Chang FY, Nelson K, Hageman GS, Bernstein P (2019). n-3 PUFA Supplementation Alters Retinal Very-Long-Chain-PUFA Levels and Ratios in Diabetic Animal Models. Molecular nutrition & food research, 63(15), e1801058.
  29. Iannaccone A, Brewer CC, Cheng P, Duncan JL, Maguire MG, Audo I, Ayala AR, Bernstein PS, Bidelman GM, Cheetham JK, Doty RL, Durham TA, Hufnagel RB, Myers MH, Stingl K, Zein WM, Foundation Fighting Blindness Consortium Investigator Group (2021). Auditory and olfactory findings in patients with USH2A-related retinal degeneration-Findings at baseline from the rate of progression in USH2A-related retinal degeneration natural history study (RUSH2A). American journal of medical genetics. Part A, 185, 3717-3727.
  30. Addo EK, Gorusupudi A, Allman S, Bernstein P (2021). The Lutein and Zeaxanthin in Pregnancy (L-ZIP) study-carotenoid supplementation during pregnancy: ocular and systemic effects-study protocol for a randomized controlled trial. Trials, 22(1), 300.
  31. Obana A, Gohto Y, Gellermann W, Ermakov IV, Sasano H, Seto T, Bernstein P (2019). Skin Carotenoid Index in a large Japanese population sample. Scientific reports, 9(1), 9318.
  32. Obana A, Gohto Y, Nakazawa R, Moriyama T, Gellermann W, Bernstein P (2020). Effect of an antioxidant supplement containing high dose lutein and zeaxanthin on macular pigment and skin carotenoid levels. Scientific reports, 10(1), 10262.
  33. Andersen KM, Sauer L, Gensure RH, Hammer M, Bernstein P (2018). Characterization of Retinitis Pigmentosa Using Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO). Translational vision science & technology, 7(3), 20.
  34. Green-Gomez M, Bernstein PS, Curcio CA, Moran R, Roche W, Nolan J (2019). Standardizing the Assessment of Macular Pigment Using a Dual-Wavelength Autofluorescence Technique. Translational vision science & technology, 8(6), 41.
  35. Vitale AS, Sauer L, Modersitzki NK, Bernstein P (2020). Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO) in Patients with Choroideremia. Translational vision science & technology, 9(10), 33.
  36. Sauer L, Vitale AS, Milliken CM, Modersitzki NK, Blount JD, Bernstein P (2020). Autofluorescence Lifetimes Measured with Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO) Are Affected by Age, but Not by Pigmentation or Gender. Translational vision science & technology, 9(9), 2.
  37. Zhai Y, Xu M, Dimopoulos IS, Birch DG, Bernstein PS, Holt J, Kirn D, Francis P, MacDonald I (2020). Quantification of RPE Changes in Choroideremia Using a Photoshop-Based Method. Translational vision science & technology, 9(7), 21.
  38. Goerdt L, Sauer L, Vitale AS, Modersitzki NK, Fleckenstein M, Bernstein P (2021). Comparing Fluorescence Lifetime Imaging Ophthalmoscopy in Atrophic Areas of Retinal Diseases. Translational vision science & technology, 10(7), 11.
  39. Cheng JL, Farnsworth K, Bernstein P (2018). Choroideremia in a Woman With Turner Syndrome. JAMA ophthalmology, 136(9), 1076-1078.
  40. Ronquillo CC, Wegner K, Calvo CM, Bernstein P (2018). Genetic Penetrance of Macular Telangiectasia Type 2. JAMA ophthalmology, 136(10), 1158-1163.
  41. Bernstein P (2019). Does Dark Chocolate Enhance Visual Function?. JAMA ophthalmology, 137(12), 1380.
  42. Strauss RW, Kong X, Ho A, Jha A, West S, Ip M, Bernstein PS, Birch DG, Cideciyan AV, Michaelides M, Sahel JA, Sunness JS, Traboulsi EI, Zrenner E, Pitetta S, Jenkins D, Hariri AH, Sadda S, Scholl HPN, ProgStar Study Group (2019). Progression of Stargardt Disease as Determined by Fundus Autofluorescence Over a 12-Month Period: ProgStar Report No. 11. JAMA ophthalmology, 137(10), 1134-1145.
  43. Hicks PM, Haaland B, Feehan M, Crandall AS, Pettey JH, Nuttall E, Self W, Hartnett ME, Bernstein P, Vitale A, Shakoor A, Shulman JP, Sieminski SF, Kim I, Owen LA, Murtaugh MA, Noyes A, DeAngelis M (2020). Systemic Disease and Ocular Comorbidity Analysis of Geographically Isolated Federally Recognized American Indian Tribes of the Intermountain West. Journal of clinical medicine, 9(11),
  44. Trujillo Tanner C, Caserta MS, Kleinschmidt JJ, Clayton MS, Bernstein PS, Guo J (2018). Conducting Research With Older Adults With Vision Impairment: Lessons Learned and Recommended Best Practices. Gerontology & geriatric medicine, 4, 2333721418812624.
  45. Sauer L, Calvo CM, Vitale AS, Henrie N, Milliken CM, Bernstein P (2019). Imaging of Hydroxychloroquine Toxicity with Fluorescence Lifetime Imaging Ophthalmoscopy. Ophthalmology. Retina, 3(10), 814-825.
  46. Arunkumar R, Gorusupudi A, Bernstein P (2020). The macular carotenoids: A biochemical overview. Biochimica et biophysica acta. Molecular and cell biology of lipids, 1865(11), 158617.
  47. Hicks PM, Melendez SAC, Vitale A, Self W, Hartnett ME, Bernstein P, Morgan DJ, Feehan M, Shakoor A, Kim I, Owen LA, DeAngelis M (2019). Genetic Epidemiologic Analysis of Hypertensive Retinopathy in an Underrepresented and Rare Federally Recognized Native American Population of the Intermountain West. Journal of community medicine & public health, 3(1),
  48. Rai BB, Morley MG, Zangmo P, Tschering T, Khatiwara AN, Bernstein PS, Maddes (2020). Surgical Management of VR Patients in Bhutan.
  49. Cheng V, Rallabandi R, Gorusupudi A, Lucas S, Rognon G, Bernstein PS, Rainier JD, Conboy J (2022). Influence of very-long-chain polyunsaturated fatty acids on membrane structure and dynamics. Biophysical journal, 121(14), 2730-2741.
  50. Bernstein P (2022). Nourishing Better Vision: The ARVO 2021 Mildred Weisenfeld Award Lecture. Investigative ophthalmology & visual science, 63(3), 13.
  51. Rai BB, Morley MG, Bernstein PS, Maddess (2022). Severity of age-related macular degeneration at first presentation in Bhutan: a 3-year national study. BMC ophthalmology, 22(1), 298.
  52. Li B, Vachali P, Chang FY, Gorusupudi A, Arunkumar R, Shi L, Rognon GT, Frederick JM, Bernstein P (2022). HDL is the primary transporter for carotenoids from liver to retinal pigment epithelium in transgenic ApoA-I-/-/Bco2-/- mice. Archives of biochemistry and biophysics, 716, 109111.
  53. Takayanagi Y, Obana A, Muto S, Asaoka R, Tanito M, Ermakov IV, Bernstein PS, Gellermann (2021). Relationships between Skin Carotenoid Levels and Metabolic Syndrome. Antioxidants (Basel, Switzerland), 11(1),
  54. Obana A, Gohto Y, Asaoka R, Gellermann W, Bernstein P (2021). Lutein and Zeaxanthin Distribution in the Healthy Macula and Its Association with Various Demographic Factors Examined in Pseudophakic Eyes. Antioxidants (Basel, Switzerland), 10(12),
  55. Lakk M, Hoffmann GF, Gorusupudi A, Enyong E, Lin A, Bernstein PS, Toft-Bertelsen T, MacAulay N, Elliott MH, Kri'aj (2021). Membrane cholesterol regulates TRPV4 function, cytoskeletal expression, and the cellular response to tension. Journal of lipid research, 62, 100145.
  56. Rai BB, Essex RW, Morley MG, Bernstein PS, van Kleef JP, Maddess (2023). Prevalence and severity of diabetic retinopathy at first presentation to vitreoretinal services in Bhutan: a 3-year national study. Japanese journal of ophthalmology,
  57. Arunkumar R, Li B, Addo EK, Hartnett ME, Bernstein P (2023). Prenatal Carotenoid Supplementation With Lutein or Zeaxanthin Ameliorates Oxygen-Induced Retinopathy (OIR) in Bco2-/- Macular Pigment Mice. Investigative ophthalmology & visual science, 64(4), 9.
  58. Li B, George EW, Vachali P, Chang FY, Gorusupudi A, Arunkumar R, Giauque NA, Wan Z, Frederick JM, Bernstein P (2023). Mechanism for the selective uptake of macular carotenoids mediated by the HDL cholesterol receptor SR-BI. Experimental eye research, 229, 109429.
  59. Thapa R, Addo EK, Ruit S, Bernstein P (2023). Assessment of Skin Carotenoid Measurement as a Means to Detect Vitamin A Deficiency in Children and Pregnant Women of Nepal. The Journal of nutrition, 153(4), 1211-1219.
  60. Green CR, Bonelli R, Ansell BRE, Tzaridis S, Handzlik MK, McGregor GH, Hart B, Trombley J, Reilly MM, Bernstein PS, Egan C, Fruttiger M, Wallace M, Bahlo M, Friedlander M, Metallo CM, Gantner M (2023). Divergent amino acid and sphingolipid metabolism in patients with inherited neuro-retinal disease. Molecular metabolism, 72, 101716.
  61. Etheridge T, Swiston C, Harrie RP, Bernstein P (2022). Acute post-traumatic endophthalmitis secondary to Bacillus pumilus/safensis. Retinal cases & brief reports,
  62. Li B, Gorusupudi A, Arunkumar R, Bernstein P (2022). Extraction, detection, and imaging of the macular carotenoids. Methods in enzymology, 674, 185-213.
  63. Sauer L, Andersen KM, Dysli C, Zinkernagel MS, Bernstein PS, Hammer (2018). Review of clinical approaches in fluorescence lifetime imaging ophthalmoscopy (Erratum). Journal of biomedical optics, 23(9), 1.
  64. Sauer L, Vitale AS, Jacoby RS, Hart B, Bernstein P (2023). FLUORESCENCE LIFETIME IMAGING OPHTHALMOSCOPY IN PATIENTS WITH MACULAR TELANGIECTASIA TYPE 2 WITH AND WITHOUT DIABETES. Retina (Philadelphia, Pa.), 43(9), 1597-1607.
  65. Addo EK, Allman SJ, Arunkumar R, Gorka JE, Harrison DY, Varner MW, Bernstein P (2023). Systemic Effects of Prenatal Carotenoid Supplementation in the Mother and her Child: The Lutein and Zeaxanthin in Pregnancy (L-ZIP) Randomized Trial -Report Number 1. The Journal of nutrition, 153(8), 2205-2215.
  66. Addo EK, Hartnett ME, Bernstein P (2023). The value of pre-symptomatic genetic risk assessment for age-related macular degeneration: the Moran AMD Genetic Testing Assessment (MAGENTA) study-a study protocol for a randomized controlled trial. Trials, 24(1), 414.
  67. Eade KT, Ansell BRE, Giles S, Fallon R, Harkins-Perry S, Nagasaki T, Tzaridis S, Wallace M, Mills EA, Farashi S, Johnson A, Sauer L, Hart B, Diaz-Rubio ME, Bahlo M, Metallo C, Allikmets R, Gantner ML, Bernstein PS, Friedlander (2023). iPSC-derived retinal pigmented epithelial cells from patients with macular telangiectasia show decreased mitochondrial function. The Journal of clinical investigation, 133(9),
  68. Gorusupudi A, Nwagbo U, Bernstein P (2023). Role of VLC-PUFAs in Retinal and Macular Degeneration. Advances in experimental medicine and biology, 1415, 257-261.
  69. Amoaku WM, Cushley L, Silvestri V, Akafo S, Amissah-Arthur KN, Lartey S, Hageman CN, Pappas CM, Hubbard WC, Bernstein PS, Vitale A, Roberts M, Virgili G, Hageman GS, Silvestri G, Ghana AMD Study Grou (2023). Vitreomacular interface abnormalities in the Ghanaian African. Eye (London, England),
  70. Posselli NR, Bernstein PS, Abbott J (2023). Eye-mounting goggles to bridge the gap between benchtop experiments and in vivo robotic eye surgery. Scientific reports, 13(1), 15503.
  71. Nwagbo U, Parvez S, Maschek JA, Bernstein P (2024). Elovl4b knockout zebrafish as a model for ocular very-long-chain PUFA deficiency. Journal of lipid research, 65(3), 100518.
  72. Bernstein P (2024). Potassium Iodate Retinotoxicity after an Overdose of Anti-Radiation Pills: A Case of Apocalyptic Retinopathy. Retinal cases & brief reports,
  73. Addo EK, Gorka JE, Allman SJ, Harrison DY, Sharifzadeh M, Hoffman RO, Hartnett ME, Varner MW, Bernstein P (2024). Ocular Effects of Prenatal Carotenoid Supplementation in the Mother and Her Child: The Lutein and Zeaxanthin in Pregnancy (L-ZIP) Randomized Trial - Report Number 2. Ophthalmology science, 4(5), 100537.
  74. Strauss RW, Lang L, Ho A, Jha A, Ip M, Bernstein PS, Birch DG, Cideciyan AV, Michaelides M, Audo I, Sunness JS, Traboulsi EI, Zrenner E, Sadda SR, Janeschitz-Kriegl L, West S, Kong X, Scholl HPN, ProgStar Study Grou (2024). The Progression of Stargardt Disease as Determined by Spectral-Domain Optical Coherence Tomography over a 24-Month Period (ProgStar Report No. 18). Ophthalmic research, 67(1), 435-447.
  75. Li B, Chang FY, Wan Z, Giauque NA, Addo EK, Bernstein P (2024). Imaging macular carotenoids and their related proteins in the human retina with confocal resonance Raman and fluorescence microscopy. Experimental eye research, 247, 110043.
  76. Zucker CL, Bernstein PS, Schalek RL, Lichtman JW, Dowling J (2024). High-throughput ultrastructural analysis of macular telangiectasia type 2. Frontiers in ophthalmology, 4, 1428777.
  77. Yang ZH, Gorusupudi A, Lydic TA, Mondal AK, Sato S, Yamazaki I, Yamaguchi H, Tang J, Rojulpote KV, Lin AB, Decot H, Koch H, Brock DC, Arunkumar R, Shi ZD, Yu ZX, Pryor M, Kun JF, Swenson RE, Swaroop A, Bernstein PS, Remaley A (2023). Dietary fish oil enriched in very-long-chain polyunsaturated fatty acid reduces cardiometabolic risk factors and improves retinal function. iScience, 26(12), 108411.
  78. Micevych PS, Fleckenstein M, Bernstein P (2025). Delayed-onset Moraxella nonliquefaciens endophthalmitis following intravitreal injection. American journal of ophthalmology case reports, 39, 102370.
  79. Vincent A, Liang W, Maguire MG, Duncan JL, Ayala AR, Bernstein PS, Carroll J, Cheetham JK, Durham TA, Farsiu S, Hoyng CB, Huckfeldt RM, Jaffe GJ, Loo J, Pennesi ME, Sahel JA, Singh MS, Zemborain ZZ, Birch DG, Lad EM, Foundation Fighting Blindness Clinical Consortium Investigator Grou (2025). Natural History of Microperimetry and Optical Coherence Tomography in USH2A-Retinopathy: A Structure-Function Association Study. American journal of ophthalmology, 276, 336-349.
  80. Bernstein P (2025). POTASSIUM IODATE RETINOTOXICITY AFTER AN OVERDOSE OF ANTIRADIATION PILLS: A CASE OF APOCALYPTIC RETINOPATHY. Retinal cases & brief reports, 19(2), 145-147.
  81. Bernstein P (2025). A CASE REPORT OF TEMPORAL MACULAR THINNING ASSOCIATED WITH ALPORT SYNDROME. Retinal cases & brief reports, 19(2), 157-159.
  82. Posselli NR, Hwang ES, Olson ZJ, Nagiel A, Bernstein PS, Abbott J (2025). Head-mounted surgical robots are an enabling technology for subretinal injections. Science robotics, 10(99), eadp7700.
  83. Thapa R, Ruit S, Bernstein P (2025). Assessment of Skin Carotenoids among School Children. Journal of Nepal Health Research Council, 22(4), 654-661.

Review

  1. Grant MB, Bernstein PS, Boesze-Battaglia K, Chew E, Curcio CA, Kenney MC, Klaver C, Philp NJ, Rowan S, Sparrow J, Spaide RF, Taylor (2022). Inside out: Relations between the microbiome, nutrition, and eye health. Experimental eye research, 224, 109216.
  2. Nwagbo U, Bernstein P (2023). Understanding the Roles of Very-Long-Chain Polyunsaturated Fatty Acids (VLC-PUFAs) in Eye Health. Nutrients, 15(14),
  3. Arunkumar R, Bernstein P (2023). Macular Pigment Carotenoids and Bisretinoid A2E. Advances in experimental medicine and biology, 1415, 15-20.

Editorial

  1. Bernstein PS, Sauer (2019). Fluorescence Lifetime Imaging Ophthalmoscopy: A New Era of Autofluorescence Imaging of the Human Retina. Retina (Philadelphia, Pa.), 39(5), 817-819.
  2. Sauer L, Bernstein P (2023). Macular Telangiectasia Type 2 versus Tamoxifen Retinopathy: How to Hit a Diagnostic Bullseye. Ophthalmology. Retina, 7(2), 97-100.

Letter

  1. Simonett JM, Shakoor A, Bernstein P (2021). Intentional retinal injury with handheld lasers is an underrecognized form of self-harm. Journal of affective disorders, 281, 503-504.

Other

  1. Kuppermann BD, Bernstein P, Mones J, Do DV, Neumann R, Rosenfeld P (2019). ISOPT Clinical Hot Topic Panel Discussion on Medical Treatment of Retinal Diseases. Journal of ocular pharmacology and therapeutics, 35(8), 424-432.